“…Moreover, cartilage fragments contain abundant stem cells, particularly cartilage-derived stem or progenitor cells (CSPCs), which have the potential to promote tendon-bone healing [ 10 , 11 ]. A study demonstrated that cartilage fragments could prevent femoral tunnel widening after ACLR [ 12 ] but could not regenerate sufficient cartilage tissues at the site of ACL insertion to achieve enthesis healing. Additional therapeutics are needed to promote tendon-bone healing in ACLR.…”